相关实验视频

Updated: Jun 24, 2025

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia

Published on: October 19, 2014

解开毛状细胞白血病的线程,超越形态,进入分子层面

Danielle Brazel¹, David Hermel¹, Pranav Gandhi²

¹Division of Hematology and Oncology, Scripps Clinic, La Jolla CA.

Clinical lymphoma, myeloma & leukemia

|June 7, 2024

概括

毛细胞白血病 (HCL) 治疗正在发展,超出标准的纯素类型,因为经常复发. 新型BRAF抑制剂和其他向疗法为治疗这种罕见的白血病提供了新的希望.

科学领域:

血液学血液学血液学
在瘤学瘤学.
罕见疾病罕见疾病

背景情况:

毛细胞白血病 (HCL) 是一种罕见的恶性瘤,具有显著的分子异质性.
标准的治疗与纯氨酸核类相似物产生高的初始响应率,但往往跟随着复发.

研究的目的:

提供对HCL.目前和新兴治疗策略的全面审查.
讨论HCL治疗的疗效,安全性和未来的方向.

主要方法:

关于HCL治疗选择的现有文献的审查.
来自临床试验和病例系列的疗效和安全数据的分析.
探索试验性药物和新的治疗点.

主要成果:

纯氨酸核酸类型是标准的预先治疗,但有局限性.
有或没有Rituximab的BRAF抑制剂在耐火和未经治疗的HCL中表现有前途.
在HCL变异病例中,对类相似物反应不那么强烈.

结论:

对于HCL的治疗领域正在扩大,有针对性的疗法正在扩大.
新型药物和组合疗法对于改善HCL的结果至关重要.
了解HCL的分子通路是开发未来治疗的关键.

关键词:

这就是BRAF.克拉德里宾 (cladribine) 是一种药物.分子测试是分子测试.里图西马布 (Rituximab) 是一种药物.有针对性的治疗.

更多相关视频

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up

Published on: March 26, 2018

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma

Published on: December 28, 2015

相关概念视频

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...